Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15318 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Sandeep Sainathan and 3 co-authors. Institution: Division of Cardiothoracic Surgery, University of Miami, Miami, USA. Major MEDLINE topics: Heart-Lung Transplantation, Heart Transplantation, Heart Defects, Congenital. Cited 1 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objective
Pediatric Heart‐lung transplant (HLTX) is performed for endstage congenital heart disease (CHD) with irreversible pulmonary hypertension or non‐congenital heart disease (NCHD) with end‐stage heart and lung disease. CHD could influence the outcomes of HTLX due to increased complexity of the operation as compared to NCHD. In this study we evaluated the influence of cardiac diagnosis on outcomes of pediatric HTLX.
Methods
The UNOS database (1987–2022) was queried for primary HTLX in patients
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiothoracic Surgery, University of Miami, Miami, USA.
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, USA.
ORCID profiles: Sandeep Sainathan, Pablo Sanchez
Cite
APA
Sainathan, S., Ryan, J., Mullinari, L., & Sanchez, P. (2024). Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15318
Vancouver
Sainathan S, Ryan J, Mullinari L, Sanchez P. Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15318
BibTeX
@article{Sainathan2024,
author = {Sainathan, Sandeep and Ryan, John and Mullinari, Leonardo and Sanchez, Pablo},
title = {Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15318}
}
EUVIMED